scispace - formally typeset
Search or ask a question
Institution

Boston Children's Hospital

HealthcareBoston, Massachusetts, United States
About: Boston Children's Hospital is a healthcare organization based out in Boston, Massachusetts, United States. It is known for research contribution in the topics: Population & Medicine. The organization has 165409 authors who have published 215589 publications receiving 6885627 citations.


Papers
More filters
Journal ArticleDOI
TL;DR: The addition of autologous BMT to four courses of intensive chemotherapy substantially reduces the risk of relapse in all risk groups, leading to improvement in long-term survival.

564 citations

Journal ArticleDOI
TL;DR: The airway epithelium acts as a frontline defense against respiratory viruses, not only as a physical barrier and through the mucociliary apparatus but also through its immunological functions, which initiates multiple innate and adaptive immune mechanisms which are crucial for efficient antiviral responses.
Abstract: The airway epithelium acts as a frontline defense against respiratory viruses, not only as a physical barrier and through the mucociliary apparatus but also through its immunological functions. It initiates multiple innate and adaptive immune mechanisms which are crucial for efficient antiviral responses. The interaction between respiratory viruses and airway epithelial cells results in production of antiviral substances, including type I and III interferons, lactoferrin, β-defensins, and nitric oxide, and also in production of cytokines and chemokines, which recruit inflammatory cells and influence adaptive immunity. These defense mechanisms usually result in rapid virus clearance. However, respiratory viruses elaborate strategies to evade antiviral mechanisms and immune responses. They may disrupt epithelial integrity through cytotoxic effects, increasing paracellular permeability and damaging epithelial repair mechanisms. In addition, they can interfere with immune responses by blocking interferon pathways and by subverting protective inflammatory responses toward detrimental ones. Finally, by inducing overt mucus secretion and mucostasis and by paving the way for bacterial infections, they favor lung damage and further impair host antiviral mechanisms.

564 citations

Journal ArticleDOI
TL;DR: This article summarizes the understanding of neuroblastoma biology and prognostic features and discusses their impact on current and proposed risk stratification schemas, risk-based therapeutic approaches, and the development of novel therapies for patients at high risk for failure.
Abstract: Neuroblastoma, a neoplasm of the sympathetic nervous system, is the second most common extracranial malignant tumor of childhood and the most common solid tumor of infancy. Neuroblastoma is a heterogeneous malignancy with prognosis ranging from near uniform survival to high risk for fatal demise. Neuroblastoma serves as a paradigm for the prognostic utility of biologic and clinical data and the potential to tailor therapy for patient cohorts at low, intermediate, and high risk for recurrence. This article summarizes our understanding of neuroblastoma biology and prognostic features and discusses their impact on current and proposed risk stratification schemas, risk-based therapeutic approaches, and the development of novel therapies for patients at high risk for failure.

564 citations

Journal ArticleDOI
TL;DR: Decisions should be based first on the age of the child, then on clinical and epidemiologic considerations, and finally, on the findings on chest radiography.
Abstract: Pneumonia remains a common and potentially serious infection in children. This review summarizes the problems involved in making the diagnosis and establishing a cause and offers a practical guide to treatment. Decisions should be based first on the age of the child, then on clinical and epidemiologic considerations, and finally, on the findings on chest radiography.

564 citations

Journal ArticleDOI
TL;DR: The developments that led to the approval of enzyme replacement therapy with recombinant human alpha-glucosidase from Chinese hamster ovary cells by the US Food and Drug Administration and European Medicines Agency in 2006 are discussed and clinical practice is reviewed.

563 citations


Authors

Showing all 165661 results

NameH-indexPapersCitations
Walter C. Willett3342399413322
Frederick E. Shelton3271485295883
Robert Langer2812324326306
Graham A. Colditz2611542256034
Frank B. Hu2501675253464
George M. Whitesides2401739269833
Eugene Braunwald2301711264576
Ralph B. D'Agostino2261287229636
Mark J. Daly204763304452
Eric B. Rimm196988147119
Virginia M.-Y. Lee194993148820
Bernard Rosner1901162147661
Stuart H. Orkin186715112182
Mark Hallett1861170123741
Ralph Weissleder1841160142508
Network Information
Related Institutions (5)
Baylor College of Medicine
94.8K papers, 5M citations

94% related

University of Texas Health Science Center at Houston
42.5K papers, 2.1M citations

93% related

Mayo Clinic
169.5K papers, 8.1M citations

93% related

University of Colorado Denver
57.2K papers, 2.5M citations

93% related

Icahn School of Medicine at Mount Sinai
76K papers, 3.7M citations

93% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
202380
2022447
202119,544
202016,558
201913,868
201812,020